Ono Pharmaceutical Co Ltd 2018 IR
The report highlights ONO PHARMACEUTICAL's performance and sustainability initiatives for the fiscal year ended March 31, 2018. The company achieved a 7.0% increase in revenue to 261.8 billion yen, driven by expanded sales of key products like OPDIVO, despite a 50% drug price cut in Japan. ONO expanded its development pipeline through active licensing and global alliances, and advanced its open innovation strategy with over 200 joint research projects. On the environmental front, the company reduced energy-derived CO2 emissions by 10.1% compared to the 2005 base year. Additionally, ONO promoted diversity and health management, establishing the Health Up Committee and achieving a 99.1% comprehensive medical examination rate among employees.
Company: Ono Pharmaceutical Co Ltd
Sector: Health Care
Country: Japan
Year: 2018
Type: IR
Pages: 120
Ono Pharmaceutical Co Ltd
Corporate Report
The report highlights ONO PHARMACEUTICAL's performance and sustainability initiatives for the fiscal year ended March 31, 2018. The company achieved a 7.0% increase in revenue to 261.8 billion yen, driven by expanded sales of key products like OPDIVO, despite a 50% drug price cut in Japan. ONO expanded its development pipeline through active licensing and global alliances, and advanced its open innovation strategy with over 200 joint research projects. On the environmental front, the company reduced energy-derived CO2 emissions by 10.1% compared to the 2005 base year. Additionally, ONO promoted diversity and health management, establishing the Health Up Committee and achieving a 99.1% comprehensive medical examination rate among employees.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Apr 1, 2017 - Mar 31, 2018
Fiscal Year
2017
Published
Aug 1, 2018
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees